Powerful Patient Stories Make Sparks Fly for FDA Advisory Committee
On October 12, World Sight Day, a Food and Drug Administration (FDA) advisory committee voted unanimously 16-0 in favor of recommending the approval of Luxturna, a gene therapy developed by Spark [...]